Growth in the ophthalmic lasers market is likely to be centered to the Asia-Pacific region. This can be attributed to the high prevalence of ophthalmic disorders, rising prevalence of chronic diseases, growth in geriatric population, and initiatives for the prevention of blindness and vision impairment.

Browse 69 market data tables and 36 figures spread through 149 pages and in-depth TOC on “Ophthalmic Lasers Market“.

http://www.marketsandmarkets.com/Market-Reports/ophthalmic-laser-market-251971654.html

The global ophthalmic lasers market is segmented on the basis of product types, applications, end users, and regions. On the basis of product type, the global market is segmented into femtosecond lasers, excimer lasers, Nd:YAG lasers, diode lasers, and other lasers. The femtosecond lasers segment is expected to account for the largest share of the market and is projected to grow at the highest CAGR during the forecast period.

According to WHO, China alone accounts for ~18% of the world’s blind population. The major cause of blindness in China is cataract. According to WHO, 50% of the country’s blindness cases are caused due to cataract and approximately 400,000 people become completely blind due to cataract alone. Based on estimates from the Brien Holden Vision Institute China has the highest prevalence of myopia globally, with approximately 600 million cases in 2009. Chronic disorders such as diabetes are also prevalent in China.

Moreover, there is a rapid growth in geriatric population in China which in turn is resulting in rapid rise in age-related vision disorders. Hence, the Chinese government has started blindness prevention and treatment projects focused on surgical interventions for cataracts. Additionally, Non-governmental development organizations (NGDOs) such as Amity Foundation (China) and Asia Foundation for the Prevention of Blindness (Hong Kong, China) are collaborating with WHO and Ministry of Health for the delivering eye care services in 19 of the 31 provinces in China. The vast patient pool for treatable vision impairment various initiatives undertaken by the government are expected to raise the number of surgeries in China, thereby creating a demand for ophthalmic lasers.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=251971654

The key players in the market include Alcon Laboratories, Inc. (U.S.), Abbott Medical Optics, Inc. (U.S.), Carl Zeiss Meditec AG (Germany), Bausch & Lomb Incorporated (U.S.), Ellex Medical Lasers Limited (Australia), Topcon Corporation (Japan), Ziemer Ophthalmic Systems AG (Switzerland), IRIDEX Corporation (U.S.), NIDEK Co., Ltd. (Japan), and Lumenis Ltd. (Israel).